ADGM — Adagio Medical Holdings, Inc Common Stock
NASDAQ · Healthcare · Medical Devices
$0.52
+$0.01 (+2.26%)
Adagio Medical Holdings, Inc Common Stock (ADGM) is a medical devices company listed on NASDAQ. It is led by Todd Usen, based in 26051 Merit Circle, Laguna Hills, CA, United States, 92653, with about 41 employees. Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
Latest reported ADGM revenue for 2025-09-30 was $0. Net income was -$21.8M. ADGM currently screens at market cap $15.5M.
Use this ADGM page for company research — sector, financials, and the latest filing takeaway — not a live tape. The session quote (last, range, volume) lives on the ADGM quote page. Cached 10-K, 10-Q, 8-K, and Form 4 exhibits are on the ADGM SEC filings page. Lician reads the product cache first so this HTML stays unique to Adagio Medical Holdings, Inc Common Stock even when a live quote feed is slow.
About Adagio Medical Holdings, Inc Common Stock
Adagio Medical Holdings, Inc., a medical technology company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature ablation (ULTA) catheter and system; vCLAS ventricular ULTC catheter; and Cryopulse pulsed field cryoablation catheters. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California.
ADGM Key Statistics
Market Cap
$15.55M
Volume
435,387
Previous Close
$0.65
Day Range
$0.56 – $0.66
P/B Ratio
2.72
EPS
-$3.70
Revenue
$269.00K
Net Income
-$53.76M
Gross Profit
$0.00
Free Cash Flow
$0.00
Revenue Growth
-10.3%
Profit Margin
-19986.2%
Employees
41
ADGM Financials
Annual income statement in USD. Latest reported periods first.
| Line | FY2024 | FY2023 |
|---|---|---|
| Revenue | $269.00K | $300.00K |
| Cost of Revenue | $0.00 | $0.00 |
| Gross Profit | $0.00 | $0.00 |
| Operating Income | $0.00 | $0.00 |
| Net Income | -$53.76M | -$36.59M |
| EPS (Diluted) | -$3.70 | -$48.16 |
Total Assets
$48.45M
Total Debt
$0.00
Shareholders' Equity
$0.00
Cash & Equivalents
$20.59M
Operating Cash Flow
-$13.47M
Free Cash Flow
$0.00
Adagio Medical Holdings, Inc Common Stock Company Information
- CEO & Director
- Todd Usen
- Headquarters
- 26051 Merit Circle, Laguna Hills, CA, United States, 92653
- Website
- adagiomedical.com
- Phone
- 949 348 1188
- IPO / Founded
- 2024-08-01
- Sector
- Healthcare
- Industry
- Medical Devices